These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10628321)

  • 41. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
    Tsao H; Zhang X; Benoit E; Haluska FG
    Oncogene; 1998 Jul; 16(26):3397-402. PubMed ID: 9692547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles.
    Kurose K; Bando K; Fukino K; Sugisaki Y; Araki T; Emi M
    Jpn J Cancer Res; 1998 Aug; 89(8):842-8. PubMed ID: 9765621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
    Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
    J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PTEN/MMAC1 gene mutation is a rare event in soft tissue sarcomas without specific balanced translocations.
    Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Tamiya S; Tanaka K; Matsuda S; Sakamoto A; Iwamoto Y; Tsuneyoshi M
    Int J Cancer; 2003 Mar; 104(2):175-8. PubMed ID: 12569572
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma.
    Van Gele M; Leonard JH; Van Roy N; Cook AL; De Paepe A; Speleman F
    Int J Cancer; 2001 May; 92(3):409-13. PubMed ID: 11291079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia.
    Liu TC; Lin PM; Chang JG; Lee JP; Chen TP; Lin SF
    Am J Hematol; 2000 Apr; 63(4):170-5. PubMed ID: 10706759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
    Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
    Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
    Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of heterozygosity on chromosome 10q23 and mutation of the phosphatase and tensin homolog deleted from chromosome 10 tumor suppressor gene in Korean hepatocellular carcinoma patients.
    Bae JJ; Rho JW; Lee TJ; Yun SS; Kim HJ; Choi JH; Jeong D; Jang BC; Lee TY
    Oncol Rep; 2007 Oct; 18(4):1007-13. PubMed ID: 17786367
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis.
    Gasparotto D; Vukosavljevic T; Piccinin S; Barzan L; Sulfaro S; Armellin M; Boiocchi M; Maestro R
    Int J Cancer; 1999 Aug; 84(4):432-6. PubMed ID: 10404099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions.
    Li YL; Tian Z; Wu DY; Fu BY; Xin Y
    World J Gastroenterol; 2005 Jan; 11(2):285-8. PubMed ID: 15633233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate.
    Dong JT; Sipe TW; Hyytinen ER; Li CL; Heise C; McClintock DE; Grant CD; Chung LW; Frierson HF
    Oncogene; 1998 Oct; 17(15):1979-82. PubMed ID: 9788441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
    Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
    Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens.
    Liu J; Babaian DC; Liebert M; Steck PA; Kagan J
    Mol Carcinog; 2000 Nov; 29(3):143-50. PubMed ID: 11108659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats.
    Tanaka T; Iwasa Y; Kondo S; Hiai H; Toyokuni S
    Oncogene; 1999 Jun; 18(25):3793-7. PubMed ID: 10391689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors.
    Di Vizio D; Cito L; Boccia A; Chieffi P; Insabato L; Pettinato G; Motti ML; Schepis F; D'Amico W; Fabiani F; Tavernise B; Venuta S; Fusco A; Viglietto G
    Oncogene; 2005 Mar; 24(11):1882-94. PubMed ID: 15674339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Research on the mechanisms of PTEN gene inactivation in ovarian cancer].
    Lü QJ; Zhao XD; Song JY; Li XH; Ma Y; Meng H; Jiang WG
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):266-9. PubMed ID: 16181546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of loss of chromosome 10q, DMBT1 homozygous deletions, and PTEN mutations in oligodendrogliomas.
    Sanson M; Leuraud P; Aguirre-Cruz L; He J; Marie Y; Cartalat-Carel S; Mokhtari K; Duffau H; Delattre JY; Hoang-Xuan K
    J Neurosurg; 2002 Dec; 97(6):1397-401. PubMed ID: 12507139
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
    Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.
    Vlietstra RJ; van Alewijk DC; Hermans KG; van Steenbrugge GJ; Trapman J
    Cancer Res; 1998 Jul; 58(13):2720-3. PubMed ID: 9661880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.